Overview

Yasmin Post Marketing Surveillance

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
Details
Lead Sponsor:
Bayer
Treatments:
Drospirenone and ethinyl estradiol combination